These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36137754)

  • 21. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.
    Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z
    J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome.
    Kavoura E; Gakiopoulou H; Paraskevakou H; Marinaki S; Agrogiannis G; Stofas A; Boletis I; Patsouris E; Lazaris AC
    Hum Pathol; 2011 Feb; 42(2):227-35. PubMed ID: 21106221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rac1 activation in podocytes induces the spectrum of nephrotic syndrome.
    Robins R; Baldwin C; Aoudjit L; Côté JF; Gupta IR; Takano T
    Kidney Int; 2017 Aug; 92(2):349-364. PubMed ID: 28483380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased GM3 correlates with proteinuria in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Naito S; Kawashima N; Ishii D; Fujita T; Iwamura M; Takeuchi Y
    Clin Exp Nephrol; 2022 Nov; 26(11):1078-1085. PubMed ID: 35804208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal segmental glomerulosclerosis: recent advances.
    Pollak MR
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):138-42. PubMed ID: 18277145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Losing their footing: Rac1 signaling causes podocyte detachment and FSGS.
    Hall G; Spurney RF
    Kidney Int; 2017 Aug; 92(2):283-285. PubMed ID: 28709595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
    Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of focal segmental glomerulosclerosis.
    Reidy K; Kaskel FJ
    Pediatr Nephrol; 2007 Mar; 22(3):350-4. PubMed ID: 17216262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphologic Analysis of Urinary Podocytes in Focal Segmental Glomerulosclerosis.
    Shirai Y; Miura K; Yokoyama T; Horita S; Nakayama H; Seino H; Ando T; Shiratori A; Yabuuchi T; Kaneko N; Ishiwa S; Ishizuka K; Hara M; Hattori M
    Kidney360; 2021 Mar; 2(3):477-486. PubMed ID: 35369007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The podocyte as a direct target of immunosuppressive agents.
    Schönenberger E; Ehrich JH; Haller H; Schiffer M
    Nephrol Dial Transplant; 2011 Jan; 26(1):18-24. PubMed ID: 20937691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.
    Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H
    Am J Nephrol; 2000; 20(3):175-9. PubMed ID: 10878397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nephrotic syndrome in childhood].
    Reusz G; Szabó A; Fekete A
    Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal segmental glomerulosclerosis and proteinuria associated with Myo1E mutations: novel variants and histological phenotype analysis.
    Krendel M; Leh S; Garone ME; Edwards-Richards A; Lin JJ; Brackman D; Knappskog P; Mikhailov A
    Pediatr Nephrol; 2023 Feb; 38(2):439-449. PubMed ID: 35723736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ultrastructural study of podocyte alterations in non proliferative glomerulopathy].
    Sipovsky VG; Nevorotin AI; Avsiewitsch IV; Smirnov AV
    Arkh Patol; 2019; 81(3):51-58. PubMed ID: 31317931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies.
    Ye Q; Lan B; Liu H; Persson PB; Lai EY; Mao J
    Acta Physiol (Oxf); 2022 Aug; 235(4):e13850. PubMed ID: 35716094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease.
    Maeda K; Otomo K; Yoshida N; Abu-Asab MS; Ichinose K; Nishino T; Kono M; Ferretti A; Bhargava R; Maruyama S; Bickerton S; Fahmy TM; Tsokos MG; Tsokos GC
    J Clin Invest; 2018 Aug; 128(8):3445-3459. PubMed ID: 29985166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
    PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle.
    Candelier JJ; Lorenzo HK
    Cell Tissue Res; 2020 Feb; 379(2):231-243. PubMed ID: 31848752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Idiopathic nephrotic syndrome: une Arlésienne?].
    Lorenzo HK; Candelier JJ
    Med Sci (Paris); 2019; 35(8-9):659-666. PubMed ID: 31532378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases.
    Barisoni L; Schnaper HW; Kopp JB
    Clin J Am Soc Nephrol; 2007 May; 2(3):529-42. PubMed ID: 17699461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.